DEFINE-HT is the first prospective, multicenter study in heart transplant recipients designed to assess whether elevated levels of donor-derived cell-free DNA (dd-cfDNA), as measured by Prospera Heart ...
Prospective Study: A prospective study is a research design in which participants are identified and enrolled before outcomes occur, and then followed over time to observe the relationship between ...
AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced the results of its DEFINE-HT clinical trial in heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback